Evidence map›Paper›PMID 34443394›Full record

ArticleMolecules (Basel, Switzerland)2021

Response of Osteosarcoma Cell Metabolism to Platinum and Palladium Chelates as Potential New Drugs.

Ana S Martins, Ana L M Batista de Carvalho, Maria P M Marques, Ana M Gil

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. PdJournal of medicinal chemistry · 2024
    Article
  3. Article
  4. Article
  5. Effect of PdInternational journal of molecular sciences · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ana S MartinsCICECO-Aveiro Institute of Materials (CICECO/UA), Department of Chemistry, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.
Ana L M Batista de CarvalhoUnidade de I&D Química-Física Molecular, Department of Chemistry, University of Coimbra, Rua Larga, 300-535 Coimbra, Portugal.ORCID 0000-0003-1280-3321
Maria P M MarquesUnidade de I&D Química-Física Molecular, Department of Chemistry, University of Coimbra, Rua Larga, 300-535 Coimbra, Portugal.ORCID 0000-0002-8391-0055
Ana M GilCICECO-Aveiro Institute of Materials (CICECO/UA), Department of Chemistry, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.ORCID 0000-0003-3766-4364

Funding

Fundação para a Ciência e a Tecnologia UIDB/50011/2020 and UIDP/50011/2020; Centro-01-0145-FEDER-029956; UIDB/00070/2020; UIDB/50006/2020;SFRH/BD/ 111576/2015Portuguese National NMR Network (PTNMR) Project Nº 022161 (co-financed by FEDER through COMPETE 2020, POCI and PORL, and the FCT through PIDDAC)
6 · The paper itself

Abstract

This paper reports the first metabolomics study of the impact of new chelates Pt

Indexed as

Antineoplastic AgentsChelating AgentsMetabolomicsOsteosarcomaPalladiumPlatinumCell Line, TumorCisplatinHumansMetabolomeOxaliplatinAntineoplastic AgentsChelating AgentsCisplatinOxaliplatinPalladiumPlatinumendometabolomehuman osteosarcoma cellsmetabolomicsmetal chelatesNMRpalladiumplatinumspermine

Identifiers

PMID34443394
PMCPMC8401043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.